Accellta Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 19

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 2

Accellta General Information

Description

Developer of stem cell culture technologies designed to offer affordability and quality of stem cell culturing for custom-made process development and clinical applications. The company's technologies offer custom-made services for the mass production of quality human embryonic and induced pluripotent stem cells, progenitors and differentiated cells for drug discovery, regenerative medicine and research, enabling clinicians to provide a cost-effective genetic manipulation of the cells with enhanced uniformity and purity.

Contact Information

Website
www.accellta.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1 Rose Avenue
  • Malat Building, 3rd floor, Technion
  • Haifa 3200004
  • Israel
+972
Primary Industry
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • 1 Rose Avenue
  • Malat Building, 3rd floor, Technion
  • Haifa 3200004
  • Israel
+972

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Accellta Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Secondary Transaction - Private 01-Jun-2022 Completed Generating Revenue
3. Early Stage VC (Series A) 26-Oct-2014 Completed Generating Revenue
2. Grant 08-Jan-2014 $68.5K Completed Generating Revenue
1. Seed Round 01-Nov-2012 Completed Startup
To view Accellta’s complete valuation and funding history, request access »

Accellta Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A
To view Accellta’s complete cap table history, request access »

Accellta Patents

  • 26

    Total Documents Applications and Grants

  • Total Patents Families

  • 6

    Granted

  • 20

    Pending

  • Expiring in next 12 mo

Accellta Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3221435-A1 Serum free media for suspension culture of mammalian livestock pluripotent stem cells Pending 09-Jun-2021
AU-2022290408-A1 Serum free media for suspension culture of mammalian livestock pluripotent stem cells Pending 09-Jun-2021
EP-4352204-A1 Serum free media for suspension culture of mammalian livestock pluripotent stem cells Pending 09-Jun-2021
JP-2024520792-A Serum-free medium for suspension culture of mammalian livestock pluripotent stem cells Pending 09-Jun-2021
US-20240191206-A1 Serum free media for suspension culture of mammalian livestock pluripotent stem cells Pending 09-Jun-2021 C12N5/0696
To view Accellta’s complete patent history, request access »

Accellta Executive Team (7)

Name Title Board Seat
Michal Amit Ph.D Co-Founder, Chief Executive Officer and Chief Technology Officer
Yael Garfinkel Chief Financial Officer & Financial Controller
Patrick Zhang Chairman
You’re viewing 3 of 7 executive team members. Get the full list »

Accellta Board Members (8)

Name Representing Role Since
Noah Chong Self Board Member
Patrick Zhang Self Chairman
Peretz Lavie Self Board Member
Rona Samler Self Board Member
You’re viewing 4 of 8 board members. Get the full list »

Accellta Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Accellta Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Horizons Ventures Venture Capital Minority
Horizon 2020 SME Instrument Government
To view Accellta’s complete investors history, request access »

Ready to get started?

Request a free trial

Accellta FAQs

  • When was Accellta founded?

    Accellta was founded in 2012.

  • Who is the founder of Accellta?

    Michal Amit Ph.D and Itzhak Angel Ph.D are the founders of Accellta.

  • Who is the CEO of Accellta?

    Michal Amit Ph.D is the CEO of Accellta.

  • Where is Accellta headquartered?

    Accellta is headquartered in Haifa, Israel.

  • What is the size of Accellta?

    Accellta has 19 total employees.

  • What industry is Accellta in?

    Accellta’s primary industry is Biotechnology.

  • Is Accellta a private or public company?

    Accellta is a Private company.

  • What is Accellta’s current revenue?

    The current revenue for Accellta is .

  • How much funding has Accellta raised over time?

    Accellta has raised $4M.

  • Who are Accellta’s investors?

    Horizons Ventures and Horizon 2020 SME Instrument have invested in Accellta.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »